Reuters logo
BRIEF-Vertex Q1 non-gaap earnings per share $0.41
2017年4月27日 / 晚上8点14分 / 7 个月前

BRIEF-Vertex Q1 non-gaap earnings per share $0.41

April 27 (Reuters) - Vertex Pharmaceuticals Inc:

* Vertex reports first-quarter 2017 financial results

* Q1 non-gaap earnings per share $0.41

* Q1 gaap earnings per share $0.99

* Qtrly total cf product revenues were $480.6 million compared to $393.6 million for q1 of 2016

* Qtrly net product revenues from orkambi were $294.9 million compared to $223.1 million for q1 of 2016

* Qtrly net product revenues from kalydeco were $185.7 million, compared to $170.5 million for q1 of 2016

* Reiterated its 2017 guidance for orkambi revenues and combined gaap and non-gaap research and development and sg&a expense

* Increased its 2017 revenue guidance for kalydeco

* Increased its total 2017 product revenue guidance for kalydeco to $710 to $730 million Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below